864750-70-9 Usage
Description
1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate is a complex organic compound with a unique chemical structure. It is characterized by the presence of carbamoylpiperidinyl, N-methylbenzamido, and biphenyl groups, which contribute to its specific properties and potential applications.
Uses
Used in Pharmaceutical Industry:
1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate is used as a pharmaceutical compound for the treatment of various medical conditions. Its unique structure allows it to interact with specific biological targets, making it a promising candidate for drug development.
Used in Drug Synthesis:
1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate is also used in the synthesis of other pharmaceutical agents. Its versatile structure can be modified to create new drugs with improved efficacy and reduced side effects.
Used in Research and Development:
1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate serves as a valuable research tool in the field of medicinal chemistry. It can be used to study the structure-activity relationships of various drug candidates and to develop new therapeutic agents with improved pharmacological properties.
Side effects
Common adverse reactions in clinical trials (1%-10%) were headache, nasopharyngitis, upper respiratory tract infection, back pain, bronchitis, dizziness, and hypertension.
Check Digit Verification of cas no
The CAS Registry Mumber 864750-70-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,4,7,5 and 0 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 864750-70:
(8*8)+(7*6)+(6*4)+(5*7)+(4*5)+(3*0)+(2*7)+(1*0)=199
199 % 10 = 9
So 864750-70-9 is a valid CAS Registry Number.
864750-70-9Relevant articles and documents
Preparation methods of revefenacin intermediate and revefenacin
-
, (2021/05/26)
The invention relates to a synthesis method of a revefenacin intermediate, which specifically comprises the following steps: in a solvent, enabling piperidin-4-yl [1,1-biphenyl]-2-carbamate to react with methyl(2-oxyethyl) tert-butyl carbamate in the pres
New rafenacin intermediate, active electrophilic building block thereof and new preparation method of rafenacin
-
, (2021/04/26)
The invention provides a new rafenacin intermediate, an active electrophilic building block thereof and a new preparation method of rafenacin. The new rafenacin intermediate shown as the formula (II) is prepared by sequentially reacting N-methylethanolamine with a compound shown as a formula (III) and a compound shown as a formula (V), and the new rafenacin intermediate shown as the formula (II) is used for activating hydroxyl to prepare an active electrophilic block shown as a formula (VI) and then reacts with a compound shown as a formula (VII) to obtain the rafenacin shown as the formula (I). The synthetic route provided by the invention has the advantages of short reaction steps, low raw material cost, simple reaction operation, mild conditions, high conversion rate, high selectivity and convenient post-treatment, and is more suitable for industrial production.
PROCESS FOR PREPARING A BIPHENYL-2-YLCARBAMIC ACID
-
, (2012/02/01)
The invention provides a process of preparing an intermediate useful in the synthesis of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester, and a process of preparing a crystalline freebase of the ester.
